Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulated Information Leuven, BELGIUM, Boston, MA, US – June 23, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets ...
AC Immune Holds Annual General Meeting of Shareholders Shareholders approved all resolutions as proposed by the Board of Directors Lausanne, Switzerland, June 23, 2023 – AC Immune SA (NASDAQ:ACIU), a clinical-stage
Leuven, BELGIUM, Boston, MA, US – June 15, 2023 – 7 pm CET – Oxurion NV a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical... | June 15, 2023
Leuven, BELGIUM, Boston, MA, US – June 15, 2023 – 7 pm CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, has announced the completion of Tranche 3 of funding under the Subscription Agreement with Atlas Special Opportunities LLC ("Atlas”). On June 15, 2023, the Company issued 40 convertible bonds to Atlas totaling EUR one million. Under the terms of the
Regulated Information Leuven, BELGIUM, Boston, MA, US – June 12, 2023 – 8.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic... | June 12, 2023